NASH diet–fed L-DNMAM mice showed reduced hepatocyte Notch activity (Supplemental Figure 4C), as well as a marked reduction in liver Ccl2 expression and liver MCP-1 levels (Figure 5, F and G). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.